Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 7/20 | 0.70 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.49 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.49 |
| ▸ | STAT3 | P40763 | 4/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ixoside SCHEMBL29474997 | 0.90 | MAPT (0.63) | PTPN1MAPTSTAT3 | |
| Geniposide SCHEMBL28006822 | 0.89 | PTPN1 (0.70) | PTPN1MAPTSTAT3 | |
| Geniposide SCHEMBL21765150 | 0.89 | PTPN1 (0.70) | PTPN1MAPTSTAT3 | |
| Geniposide SCHEMBL16264978 | 0.89 | PTPN1 (0.70) | PTPN1MAPTSTAT3 | |
| Geniposide SCHEMBL17776267 | 0.89 | PTPN1 (0.70) | PTPN1MAPTSTAT3 | |
| SCHEMBL31228947 | 0.88 | PTPN1 (0.57) | PTPN1MAPT | |
| SCHEMBL31338951 | 0.88 | MAPT (0.63) | PTPN1MAPTSTAT3 | |
| SCHEMBL29425885 | 0.88 | MAPT (0.63) | PTPN1MAPTSTAT3 | |
| Geniposidic Acid SCHEMBL6824308 | 0.87 | PTPN1 (0.57) | PTPN1MAPTPTPN2PTPN11STAT3 | |
| SCHEMBL30904657 | 0.86 | PTPN1 (0.64) | PTPN1MAPTSTAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1383 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005693-A | Application of Jiaweidanzhi Xiaoyao powder or extract thereof in preparation of medicines for treating depression complicated with ulcerative colitis | 河南中医药大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260021152-A1 | USE OF MALE FLOWER EXTRACT OF EUCOMMIA ULMOIDES OLIVER IN PREPARATION OF FOOD OR MEDICAMENT FOR RESISTING MUSCLE AGING | UNIV ZHEJIANG (CN) | 2026-01-22 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-4379068-B1 | IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS | INSTITUT NAT DES SCIENCES APPLIQUEES DE ROUEN (FR) | 2025-06-04 | — | — | EP | claimed |
| CN-119868482-A | Chinese herbal compound composition for treating middle-late diabetic nephropathy, preparation method and quality detection method thereof | 江苏省中医院 | 2025-04-25 | — | — | CN | claimed |
| CN-119191273-B | Nitrogen-doped biomass-based porous carbon material, and preparation method and application thereof | 河北省科学院能源研究所 | 2025-02-18 | — | — | CN | claimed |
| CN-119191273-A | Nitrogen-doped biomass-based porous carbon material, and preparation method and application thereof | 河北省科学院能源研究所 | 2024-12-27 | — | — | CN | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| US-12146869-B2 | Methods and compositions for analyte quantification | MATTERWORKS INC (US) | 2024-11-19 | — | — | US | claimed |
| CN-118937532-A | Quality control method of Chinese herbal compound containing radix rehmanniae Preparata and fructus Psoraleae and its application | 湖南易能生物医药有限公司 | 2024-11-12 | — | — | CN | claimed |
| WO-2005046519-A1 | DRUG-ELUTING BIODEGRADABLE STENT | GP MEDICAL, INC. (US) | 2005-05-26 | — | — | WO | claimed |
| US-20050019404-A1 | delivering medical equipment having layers or zones containing drugs, to the target tissues for release of drugs; tissue-targeted therapy; drug delivery | GP MEDICAL, INC. | 2005-01-27 | — | — | US | claimed |
| CN-1091095-C | Method of extracting the effective components from gettama leaf by using supercritical carbon dioxide | GUTE GETTAMA DEV CO LTD ZUNYI (CN) | 2002-09-18 | — | — | CN | claimed |
| WO-2001001996-A9 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIV WESTERN AUSTRALIA (AU) | 2002-09-12 | — | — | WO | claimed |
| WO-2001001996-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2001-01-11 | — | — | WO | claimed |
| CN-1241560-A | Method of extracting the effective components from gettama leaf by using supercritical carbon dioxide | GUTE GETTAMA DEV CO LTD ZUNYI (CN) | 2000-01-19 | — | — | CN | claimed |
| WO-1996010408-A1 | CARDIOACTIVE COMPOUNDS ISOLATED FROM WOODY PERENNIALS | THE EXECUTIVE DIRECTOR OF THE WESTERN AUSTRALIAN DEPARTMENT OF CONSERVATION AND LAND MANAGEMENT (AU) | 1996-04-11 | — | — | WO | claimed |
| US-5270446-A | Crosslinking primary amine compound with iridoid compound | SUNTORY LIMITED (JP) | 1993-12-14 | — | — | US | claimed |
| US-5078750-A | HAIR DYEING BY IRIDOID GLYCOSIDES AND AGLYCONS THEREOF | TOKIWA KANPO PHARMACEUTICAL CO., LTD. (JP) | 1992-01-07 | — | — | US | claimed |
| EP-0440494-A2 | Hair dyeing | TOKIWA KANPO PHARMACEUTICAL CO., LTD. (JP) | 1991-08-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021152-A1 | USE OF MALE FLOWER EXTRACT OF EUCOMMIA ULMOIDES OLIVER IN PREPARATION OF FOOD OR MEDICAMENT FOR RESISTING MUSCLE AGING | FIS1, OPA1, TFAM | PTPN1 4494/4885MAPT 1797/4885PTPN2 4597/4885 |
| US-20050019404-A1 | delivering medical equipment having layers or zones containing drugs, to the target tissues for release of drugs; tissue-targeted therapy; drug delivery | PLAUR, ABCB1, MATR3 | PTPN1 4001/4885MAPT 2706/4885PTPN2 4289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.